Table 1 Demographic and clinical patients’ characteristics, tumor characteristics.
From: CT based radiomic approach on first line pembrolizumab in lung cancer
Characteristics | Number of patients (n = 21) | (%) |
|---|---|---|
Age | Mean 59 years (45–82) | – |
Gender (male) | 14 | 66 |
BMI | 23.74 ± 4.03 | – |
Smoke habit | ||
Current smoker | 16 | 76 |
Former smoker | 4 | 19 |
Non-smoker | 1 | 5 |
ECOG score | ||
0 | 9 | 43 |
1 | 11 | 52 |
2 | 1 | 5 |
NSCLC type | ||
Adenocarcinoma | 18 | 86 |
Squamous cell ca | 3 | 14 |
ALK | ||
Wild type | 21 | 100 |
EGFR | ||
Wild type | 20 | 95 |
Exon 19 deletion | 1 | 5 |
PD-L1 expression (> 50%) | 21 | 100 |
Brain metastasis | 6 | 29 |
Bone metastasis | 5 | 23 |
Liver metastasis | 1 | 5 |
